Jane Diggle & Nicola Milne take you through the information you need-to-know but sometimes can’t remember on how to maximise the benefits of insulin in your type 2 diabetes patients.
Diabetes Masterclass (1/3): Navigating NICE NG28
Jane Diggle & Dr Kevin Fernando take us through the implementation of the recently published update to NICE guidance on the management of Type 2 Diabetes in adults (NG28) and what it means for primary care.
SGLT2 (5/5) – SGLT2 inhibitors: Latest from NICE
Professor Cliff Bailey and Dr Martin Hadley-Brown provide a 30 minute update on the latest guidance from NICE about SGLT2 inhibitors.
SGLT2 (4/5) – SGLT2 inhibitors: What we need to know from 2021
Professor Cliff Bailey and Dr Martin Hadley-Brown provide a 30 minute update on what you need to know about SGLT2 inhibitors from the 2021 congresses.
SGLT2 inhibitors: The story so far…
Professor Cliff Bailey and Dr Martin Hadley-Brown provide a 30 minute update on what you need to know about SGLT2 inhibitors from the 2021 congresses.
GLP-1 (3/3): Translating theory into practice. An interactive case-based discussion
Su Down and Dr Kevin Fernando translate the theory into practice with case based discussion covering glucose management and initiating GLP-1 RA for CV benefit.
GLP-1 (2/3): Practicalities of starting GLP-1 receptor agonist therapy
Jane Diggle and Nicola Milne discuss GLP-1 Receptor Agonists so you can enhance your knowledge and gain confidence in the practicalities of initiating GLP-1 receptor agonists effectively in daily practice.
GLP-1 (1/3): Understanding the incretin effect and GLP-1 receptor agonist therapy
Jane Diggle and her expert colleagues will discuss GLP-1 Receptor Agonists including ‘Understanding the Incretin effect and GLP-1 Receptor Agonist Therapy’ by Professor Michael Cummings.
SGLT2 (3/5) – SGLT2 inhibitors and the kidney
Professor Cliff Bailey and Dr Pam Brown discuss the Reno-protective effects of SGLT2 inhibitors and the role of SGLT2 inhibitors in the management of diabetic kidney disease.
SGLT2 (2/5) – SGLT2 inhibitors and the heart
Professor Cliff Bailey and Dr Martin Hadley-Brown discuss the effects of SGLT2 inhibitors on cardiovascular function and the role of SGLT2 inhibitors in the management of CV disease.
SGLT2 (1/5) – Understanding SGLT2 inhibition
Professor Cliff Bailey and Professor Vinod Patel assess the clinical evidence and opportunities offered by sodium-glucose co-transporter-2 (SGLT2) inhibitors in the management of type 2 diabetes and its cardio-renal complications.
Essentials of insulin (3/3) – Maximising benefits: Minimising risks
This is the third webinar in the Essentials of Insulin series, Jane Diggle and Su down discuss maximising benefits and minimising risks, including ‘Time to inject safely’ and ‘Training and competency’.
